Autolus taps Oakley as SVP and CFO
London-based Autolus, a biopharmaceutical company focused on developing and commercializing T-cell therapies, has named Andrew J. Oakley as senior vice president and chief financial officer. Previously, Oakley worked at Sosei Group Corporation where he was executive vice president and chief financial officer. Autolus' backers include Arix Bioscience plc, Cormorant Asset Management, Nextech Invest, Syncona and Woodford Investment Management.
8 June 2018•2 mins read
